Eurofins Scientific SE (ERFSF)
USD 54.91
(0.0%)
USD 54.91
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 6.75 Billion EUR | 29.02% |
| 2022 | 5.23 Billion EUR | 12.4% |
| 2021 | 4.65 Billion EUR | -4.2% |
| 2020 | 4.85 Billion EUR | -1.34% |
| 2019 | 4.92 Billion EUR | 9.85% |
| 2018 | 4.48 Billion EUR | 33.82% |
| 2017 | 3.35 Billion EUR | 41.2% |
| 2016 | 2.37 Billion EUR | -9.42% |
| 2015 | 2.61 Billion EUR | 116.68% |
| 2014 | 1.2 Billion EUR | 9.68% |
| 2013 | 1.1 Billion EUR | 40.78% |
| 2012 | 782.97 Million EUR | 3.81% |
| 2011 | 754.26 Million EUR | 49.22% |
| 2010 | 505.47 Million EUR | 10.78% |
| 2009 | 456.26 Million EUR | -11.39% |
| 2008 | 514.89 Million EUR | 29.87% |
| 2007 | 396.46 Million EUR | 10.84% |
| 2006 | 357.7 Million EUR | 94.67% |
| 2005 | 183.74 Million EUR | 48.15% |
| 2004 | 124.02 Million EUR | 10.12% |
| 2003 | 112.62 Million EUR | 4.91% |
| 2002 | 107.35 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 5.5 Billion EUR | 0.0% |
| 2023 Q4 | 6.75 Billion EUR | 0.0% |
| 2023 FY | 6.75 Billion EUR | 29.02% |
| 2023 Q2 | 5.25 Billion EUR | 0.0% |
| 2022 Q4 | 5.23 Billion EUR | 0.0% |
| 2022 Q2 | 5.49 Billion EUR | 0.0% |
| 2022 FY | 5.23 Billion EUR | 12.4% |
| 2021 Q2 | 4.55 Billion EUR | 0.0% |
| 2021 FY | 4.65 Billion EUR | -4.2% |
| 2021 Q4 | 4.65 Billion EUR | 0.0% |
| 2020 Q2 | 4.61 Billion EUR | 0.0% |
| 2020 FY | 4.85 Billion EUR | -1.34% |
| 2020 Q4 | 4.85 Billion EUR | 0.0% |
| 2019 Q4 | 4.92 Billion EUR | 0.0% |
| 2019 Q2 | 4.94 Billion EUR | 0.0% |
| 2019 FY | 4.92 Billion EUR | 9.85% |
| 2018 Q4 | 4.48 Billion EUR | 0.0% |
| 2018 FY | 4.48 Billion EUR | 33.82% |
| 2018 Q2 | 3.38 Billion EUR | 0.0% |
| 2017 Q2 | 2.31 Billion EUR | 0.0% |
| 2017 Q4 | 3.35 Billion EUR | 0.0% |
| 2017 FY | 3.35 Billion EUR | 41.2% |
| 2016 Q2 | 2.53 Billion EUR | 0.0% |
| 2016 Q4 | 2.37 Billion EUR | 0.0% |
| 2016 FY | 2.37 Billion EUR | -9.42% |
| 2015 Q2 | 1.81 Billion EUR | 0.0% |
| 2015 FY | 2.61 Billion EUR | 116.68% |
| 2015 Q4 | 2.61 Billion EUR | 0.0% |
| 2014 FY | 1.2 Billion EUR | 9.68% |
| 2014 Q4 | 1.2 Billion EUR | 0.0% |
| 2014 Q2 | 1.29 Billion EUR | 0.0% |
| 2013 Q2 | 871.48 Million EUR | 0.0% |
| 2013 FY | 1.1 Billion EUR | 40.78% |
| 2013 Q4 | 1.1 Billion EUR | 0.0% |
| 2012 Q2 | 754.19 Million EUR | 0.0% |
| 2012 Q4 | 782.97 Million EUR | 0.0% |
| 2012 FY | 782.97 Million EUR | 3.81% |
| 2011 Q3 | 668.35 Million EUR | 14.21% |
| 2011 Q4 | 754.26 Million EUR | 12.85% |
| 2011 Q1 | 579.94 Million EUR | 14.73% |
| 2011 Q2 | 585.18 Million EUR | 0.9% |
| 2011 FY | 754.26 Million EUR | 49.22% |
| 2010 FY | 505.47 Million EUR | 10.78% |
| 2010 Q4 | 505.47 Million EUR | -2.99% |
| 2010 Q2 | 567.59 Million EUR | 27.54% |
| 2010 Q1 | 445.01 Million EUR | -2.47% |
| 2010 Q3 | 521.03 Million EUR | -8.2% |
| 2009 Q4 | 456.26 Million EUR | 0.0% |
| 2009 FY | 456.26 Million EUR | -11.39% |
| 2008 FY | 514.89 Million EUR | 29.87% |
| 2007 FY | 396.46 Million EUR | 10.84% |
| 2006 FY | 357.7 Million EUR | 94.67% |
| 2005 FY | 183.74 Million EUR | 48.15% |
| 2004 FY | 124.02 Million EUR | 10.12% |
| 2003 FY | 112.62 Million EUR | 4.91% |
| 2002 FY | 107.35 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Bio Medica Corporation | 3.6 Million USD | -187017.517% |
| Arrayit Corporation | 7.49 Million USD | -89956.91% |
| Atlantic International Corp. | 3.82 Million USD | -176235.168% |
| Biocept, Inc. | 22.01 Million USD | -30569.15% |
| Bioqual, Inc. | 18.93 Million USD | -35548.98% |
| CardioGenics Holdings Inc | 1.79 Million USD | -376027.555% |
| DermTech, Inc. | 64.75 Million USD | -10325.759% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | -818.564% |
| HTG Molecular Diagnostics, Inc. | 12.38 Million USD | -54406.886% |
| iMD Companies, Inc. | 1.67 Million USD | -403145.459% |
| IDenta Corp. | 1.01 Million USD | -666252.139% |
| Interpace Biosciences, Inc. | 28.15 Million USD | -23876.986% |
| Integrative Health Technologies, Inc. | 297.94 Thousand USD | -2265806.352% |
| InVitro International | 78.99 Thousand USD | -8546804.671% |
| Lumos Diagnostics Holdings Limited | 19.72 Million USD | -34119.678% |
| Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | -5221366.855% |
| Medical Imaging Corp. | 9.51 Million USD | -70837.68% |
| NovelStem International Corp. | 4.2 Million USD | -160410.537% |
| Optigenex Inc. | 9.57 Million USD | -70440.892% |
| PharmChem, Inc. | 558.64 Thousand USD | -1208391.23% |
| Proteome Sciences plc | 18.48 Million USD | -36414.582% |
| Response Genetics, Inc | 15.86 Million USD | -42448.686% |
| Rennova Health, Inc. | 49.66 Million USD | -13492.833% |
| RushNet, Inc. | 6.23 Million USD | -108109.788% |
| ScreenPro Security Inc. | 1.6 Million USD | -421695.254% |
| Stella Diagnostics Inc. | 18 Million USD | -37395.408% |
| StageZero Life Sciences Ltd. | 8.2 Million USD | -82191.675% |
| Todos Medical Ltd. | 50.15 Million USD | -13360.135% |